Overview

Soy Isoflavone in Combination With Radiation Therapy and Cisplatin in SCC of the Head and Neck

Status:
Completed
Trial end date:
2019-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if soy supplementation during chemotherapy and radiation therapy will decrease side effects caused by treatment. Long-lasting dry mouth is a side effect of the standard treatment, and we are testing whether soy supplementation during treatment may reduce this symptom and other side effects of chemoradiation.
Phase:
Phase 1
Details
Lead Sponsor:
Emory University
Collaborator:
Radiation Therapy Oncology Group
Treatments:
Cisplatin
Genistein